← Back to Search

Theater Program for Aging

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month follow up
Awards & highlights

Study Summary

This trial will test the effects of a theater program on physical function and stress in older adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Timed Up-and-Go
Secondary outcome measures
2-minute step test
30-sec chair stand test
Berg Balance Scale
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Theater programExperimental Treatment1 Intervention
The design of the 10-week theater program is based on the principles of acting as written and practiced by Constantin Stanislavski in his revolutionary text on acting: "An Actor Prepares" [Stanislavsky C, 1989]. The exercises target concentration, voice, physical skills, emotion memory, observation, and dramatic analysis and include 3 components: 1. Preparation for the Actor (which involves relaxation , collaboration, movement, posture, and vocality; 2. Learning the Components of the Repeatable Acting Process (which involves physicality, attention, and concentration); and 3. Synthesizing Components into Characterization (which involves creativity and emotional expression). Each of these components will be addressed during each of 20 sessions through the use of group warm ups, group ensemble exercises, and group recitations. Participants will perform physical, mental, and emotional exercises similar to those given to beginning acting students in traditional theater schools.
Group II: Wait-list controlActive Control1 Intervention
During the study period, the control group will not receive any type of intervention. However, they will be offered the same theater program experience after the primary data collection period ends.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
theater program
2021
N/A
~90

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,584 Previous Clinical Trials
2,279,989 Total Patients Enrolled
16 Trials studying Aging
1,463 Patients Enrolled for Aging

Media Library

Theater Program Clinical Trial Eligibility Overview. Trial Name: NCT04582370 — N/A
Aging Research Study Groups: Theater program, Wait-list control
Aging Clinical Trial 2023: Theater Program Highlights & Side Effects. Trial Name: NCT04582370 — N/A
Theater Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04582370 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this scientific experiment currently being accepted?

"The clinical trial, which was initially posted on October 4th 2021, is currently recruiting participants. The information hosted on clinicaltrials.gov reflects that the details of this study have been recently updated January 11th 2022."

Answered by AI

How many individuals are currently participating in this clinical research?

"Affirmative. Clinicaltrials.gov displays evidence that signup for this clinical experiment has opened, which was created on October 4th 2021 and modified as recently as January 11th 2022. 66 individuals are needed to be enlisted at one research centre."

Answered by AI
~24 spots leftby Apr 2025